Drug Injections for MS Become More Convenient

Betaseron® is now available in the US in a new “room-temperature” formula. Given via subcutaneous injection every other day for the long-term treatment of relapsing-remitting MS (RRMS), Betaseron previously needed to be refrigerated – making travel difficult for people using this medication. Presently, Betaseron is the only long-term treatment for RRMS that does not require refrigeration.

Similar to Rebif® (taken three times per week), Copaxone® (given daily) now offers a preparation that is “ready for injection.” Both are given subcutaneously for the long-term treatment of RRMS. The premixed medications are available in pre-filled syringes that eliminate the need for mixing as well as the need to switch needles after mixing – so only one needle is used. The pre-filled syringes may be used with the auto injector for greater ease and fewer injection-site reactions.